Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer have?
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer has 2,619 citations in the OpenAlex counts ScholarIQ stores.
When was Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer published?
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer has 2022 year in the ScholarIQ index.
What is the open-access status of Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer?
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer has bronze oa status in the ScholarIQ index.
What is the DOI of Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer?
The DOI for Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer is on the source record.
What is the PMID of Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer?
The PMID for Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer is on the source record.
What is the OpenAlex record for Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer?
The OpenAlex for Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer is on the source record.